Ahmet MAMUR, MEHMET KAYHAN, UĞUR BİLGE, Serkan SUNGUR, Hüseyin BALCIOĞLU, İlhami ÜNLÜOĞLU

Turkish Reliability of National Institutes of Health (NIH) patient-reported outcomes measurement information system (PROMIS®) Gas/Bloating Scale

Many other methods are used to diagnose gas and bloating in addition to invasive methods. Scales are one of these methods. In this study; our aim was to perform reliability study of the Turkish version of National Institutes of Health (NIH) Patient-Reported Outcomes Measurement Information System (PROMIS®) Gas/Bloating Scale. The Gas/Bloating scale was translated into Turkish by three researchers, and a consensus meeting was held after the translation process. The Turkish text on which the researchers agreed was translated into English by an independent professional translator. The researchers decided that there was no difference between the translated English text and the source text after they compared the two texts in terms of meaning and comprehensibility. As a result of this process, the researchers obtained the final version on which they agreed and the accuracy of which was proved by back translation. A total of 60 patients took part in this study. 29 of them (48.3%) were male, 31 of them (51.70%) were female. Mean age of participants was 39,5±17,1 years. Cronbach's alpha coefficient was found to be 0.914 for 12 scale question. This study shows that Turkish version of PROMIS-Gas/Bloating scale is reliable. We believe that this scale may be used for the objective assessment of patients with gas and bloating in clinical practice

PDF

___

1. Talley N J, Holtmann G, Agréus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol. 2000;95(6):1439-47.

2. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999:45(suppl 2):43-7.

3. Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005;128(3):580-9.

4. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413-9.

5. Seo AY, Kim N, Oh DH. Abdominal bloating: pathophysiology and treatment. J Neurogastroenterol Motil. 2013;19(4):433.

6. Spiegel BM, Hays RD, Bolus R, Melmed GY, Chang L, Whitman C, Khanna PP, Paz SH, Hays T, Reise S, Khanna D. Development of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scales. The American journal of gastroenterology, 2014;109(11):1804-14.

7. Lee AD, Spiegel BM, Hays RD, Melmed GY, Bolus R, Khanna D, Khanna PP, Chang L. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil. 2016 Dec 16. [Epub ahead of print]

8. Bland JM, Altman DG. Statistics notes: Cronbach's alpha. BMJ. 1997;314(7080):572.

9. Özseker B, Yasar NF, Bilgin M, Kurt Y, Balcioglu H, Bilge U. Turkish validation of National Institutes of Health (NIH) patientreported outcomes measurement information system (PROMISÂŪ) Gastroesophageal Reflux Disease (GERD) scale. Biomedical Research. 2016;27(2):577-81.